Current Value of Holding

$0

Shares

0

% of Portfolio

0.00%

Average Buy Price

$295

Avg closing price
Price range

36 Steven Cohen Vertex Pharmaceuticals Trades

The first Vertex Pharmaceuticals trade was made in Q2 2014. Since then Steven Cohen bought shares sixteen more times and sold shares on nineteen occasions. The investor completely sold their stake between Q2 2023 and Q4 2023.

Avg closing price
Price range
Sold -85.4 Thousand shares Q4 2023
Avg closing price $369.42
Price range $343.00 - $410.68
Sold 65.3% shares (-161 Thousand shares) Q3 2023
Avg closing price $349.73
Price range $338.18 - $362.46
Sold 4.7% shares (-12.1 Thousand shares) Q2 2023
Avg closing price $336.94
Price range $314.42 - $351.91
Increased shares by 133.2% (+148 Thousand shares) Q1 2023
Avg closing price $299.93
Price range $283.23 - $323.10
Increased shares by 3.2% (+3.44 Thousand shares) Q4 2022
Avg closing price $304.77
Price range $285.76 - $321.48
New holding (+107 Thousand shares) Q3 2022
Avg closing price $287.72
Price range $273.83 - $305.53
Sold -47.6 Thousand shares Q1 2022
Avg closing price $237.33
Price range $221.42 - $260.97
New holding (+47.6 Thousand shares) Q4 2021
Avg closing price $194.45
Price range $177.01 - $223.45
Sold -66.5 Thousand shares Q3 2021
Avg closing price $195.24
Price range $181.39 - $202.99
Sold 90.0% shares (-597 Thousand shares) Q2 2021
Avg closing price $209.17
Price range $187.49 - $221.10
Increased shares by 197.6% (+441 Thousand shares) Q1 2021
Avg closing price $219.65
Price range $207.02 - $241.31
Increased shares by 71.4% (+92.9 Thousand shares) Q4 2020
Avg closing price $229.44
Price range $207.01 - $276.09
New holding (+130 Thousand shares) Q3 2020
Avg closing price $275.88
Price range $255.65 - $303.10
Sold -115 Thousand shares Q1 2020
Avg closing price $229.39
Price range $199.77 - $247.81
Sold 41.2% shares (-80.5 Thousand shares) Q4 2019
Avg closing price $202.38
Price range $166.71 - $223.91
Increased shares by 66.4% (+77.9 Thousand shares) Q3 2019
Avg closing price $176.91
Price range $166.23 - $187.09
Increased shares by 6.0% (+6.65 Thousand shares) Q2 2019
Avg closing price $174.82
Price range $164.61 - $190.37
Increased shares by 62.3% (+42.5 Thousand shares) Q1 2019
Avg closing price $184.70
Price range $163.73 - $194.70
Sold 33.7% shares (-34.7 Thousand shares) Q4 2018
Avg closing price $173.27
Price range $151.91 - $192.21
Sold 70.2% shares (-242 Thousand shares) Q3 2018
Avg closing price $178.07
Price range $167.73 - $192.74

News about Vertex Pharmaceuticals, Inc. and Steven Cohen

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!